Diagnos Laboratorium Utama PT Tbk (DGNS) — Capital Reinvestment Ratio
Diagnos Laboratorium Utama PT Tbk (DGNS) has a Capital Reinvestment Ratio of 1.74x as of June 2025, meaning it reinvests 2% of its operating cash flow (Rp1.52 Billion) in capital expenditures (Rp2.64 Billion). See Diagnos Laboratorium Utama PT Tbk (DGNS) net asset quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Diagnos Laboratorium Utama PT Tbk Capital Reinvestment Ratio (2018–2024)
This chart tracks Diagnos Laboratorium Utama PT Tbk's Capital Reinvestment Ratio across 6 annual periods. Check Diagnos Laboratorium Utama PT Tbk (DGNS) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Diagnos Laboratorium Utama PT Tbk (2018–2024)
Year-by-year Capital Reinvestment Ratio for Diagnos Laboratorium Utama PT Tbk from 2018 to 2024. For live market cap and broader valuation context, see Diagnos Laboratorium Utama PT Tbk market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (IDR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.59x | Rp27.30 Billion | Rp43.39 Billion | ▼ -45.3% |
| 2023 | 2.91x | Rp13.18 Billion | Rp38.32 Billion | ▲ +152.3% |
| 2021 | 1.15x | Rp58.87 Billion | Rp67.84 Billion | ▲ +415.4% |
| 2020 | 0.22x | Rp26.23 Billion | Rp5.86 Billion | ▼ -10.0% |
| 2019 | 0.25x | Rp11.20 Billion | Rp2.78 Billion | ▼ -45.2% |
| 2018 | 0.45x | Rp8.47 Billion | Rp3.84 Billion | — |